OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 122 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $102,000 | -67.2% | 181,083 | 0.0% | 0.00% | – |
Q4 2015 | $311,000 | -18.6% | 181,083 | 0.0% | 0.00% | – |
Q3 2015 | $382,000 | -57.4% | 181,083 | 0.0% | 0.00% | -100.0% |
Q2 2015 | $896,000 | -36.8% | 181,083 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $1,418,000 | +29.3% | 181,083 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $1,097,000 | +59.0% | 181,083 | +11.9% | 0.00% | 0.0% |
Q3 2014 | $690,000 | -31.0% | 161,883 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $1,000,000 | +14.9% | 161,883 | +21.0% | 0.00% | 0.0% |
Q1 2014 | $870,000 | +15.4% | 133,783 | -0.0% | 0.00% | 0.0% |
Q4 2013 | $754,000 | -8.3% | 133,838 | +0.0% | 0.00% | 0.0% |
Q3 2013 | $822,000 | +4.6% | 133,821 | -0.4% | 0.00% | 0.0% |
Q2 2013 | $786,000 | – | 134,393 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management I, LLC | 1,229,287 | $9,625,000 | 44.28% |
Foresite Capital Management II, LLC | 4,200,047 | $32,886,000 | 19.48% |
Scale Management, LLC | 2,884,305 | $22,584,000 | 11.28% |
Cheyne Capital Management (UK) LLP | 1,484,409 | $11,601,000 | 2.80% |
Telemetry Investments, L.L.C. | 463,039 | $3,626,000 | 2.00% |
NEA Management Company, LLC | 3,709,000 | $29,041,000 | 1.31% |
Rock Springs Capital Management LP | 1,550,000 | $12,137,000 | 1.14% |
Rhenman & Partners Asset Management AB | 831,800 | $6,513,000 | 1.10% |
Tamarack Capital Management, LLC | 1,000,000 | $7,830,000 | 1.03% |
RA Capital Management | 1,186,229 | $9,288,000 | 0.92% |